Mark Chin

(Mr. Mark Chin)

Currently holds a position at Harpoon Therapeutics Inc

Positions

Position Company Period
Independent Director Harpoon Therapeutics Inc May 1, 2017 -
Mark Chin's trades of Pyxis Oncology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-25 2022-04-21
S Sale
1,745,761 -100.0%
3.05
USD 5,324,571 		1,745,761 -100.0% 3.05 USD 5,324,571
2021-10-15 2021-10-13
B Purchase
312,500 +21.8%
16.00
USD 5,000,000 		312,500 +21.8% 16.00 USD 5,000,000
2020-03-16 2020-03-16
US Imara Inc (IMRA)
B Purchase
187,500 +13.7%
16.00
USD 3,000,000 		187,500 +13.7% 16.00 USD 3,000,000
2019-12-10 2019-12-06
S Sale
47,752 -1.7%
19.15
USD 914,222 		47,752 -1.7% 19.15 USD 914,222
2019-02-14 2019-02-12
B Purchase
428,571 +17.4%
14.00
USD 5,999,994 		428,571 +17.4% 14.00 USD 5,999,994
// ... existing code ... // ... rest of the file ...